[Results of an open and a double-blind study of nomifensin in comparison to imipramin (author's transl)].
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001555:Benzene Derivatives / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007546:Isoquinolines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000150:complications / Q000188:drug therapy; D013997:Time Factors
D001555:Benzene Derivatives; D007546:Isoquinolines; D007099:Imipramine
Ergebnisse eines offenen und eines Doppelblindversuches von Nomifensin im Vergleich zu Imipramin